Skip to content
GenoLensGenoLens

ENO3

Chr 17p13.2

enolase 3

MANE:
ENST00000519602.6

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Acute rhabdomyolysis

    BIALLELIC, autosomal or pseudoautosomal
  • Glycogen storage disease

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Rhabdomyolysis and metabolic muscle disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

  • Hyperammonaemia

  • Ketotic hypoglycaemia

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • glycogen storage disease due to muscle beta-enolase deficiency

    0.71
  • neurodegenerative disease

    0.48
  • Exercise-induced rhabdomyolysis

    0.37
  • Thrombocytopenia

    0.26
  • hereditary disease

    0.19
  • amyotrophic lateral sclerosis

    0.15
  • kidney disorder

    0.13
  • hepatocellular carcinoma

    0.08
  • metabolic dysfunction-associated steatohepatitis

    0.05
  • malignant colon neoplasm

    0.04

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Beta-enolase

Enolase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis and the reverse reaction in gluconeogenesis. Appears to have a function in striated muscle development and regeneration

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.